Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
NIH Grants & Funding for Schwannoma | Kisho | Kisho
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Schwannoma. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
Translational / Drug DevelopmentFunded, Few Publications
6 funded grants in Translational / Drug Development but only 0 related publications found for schwannoma. This may indicate early-stage research that hasn't yet produced published results.
Gene Therapy / Cell TherapyFunded, Few Publications
2 funded grants in Gene Therapy / Cell Therapy but only 0 related publications found for schwannoma. This may indicate early-stage research that hasn't yet produced published results.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
141 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for schwannoma. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
9 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for schwannoma. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(8 grants)
These grants mention Schwannoma as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention
LARGAESPADA, DAVID·UNIVERSITY OF MINNESOTA·MINNEAPOLIS, MN
